Latest Operational Improvement News

MC Mining reports zero lost time injuries and steady progress on its flagship Makhado Project, while Uitkomst Colliery implements a turnaround plan that boosts sales despite production challenges.

Althea Group Holdings reported significant cash outflows in Q2 2025 due to one-off costs but anticipates operational improvements and revenue growth from its North American business units.

Oldfields Holdings reports constrained Q4 FY2025 sales due to limited working capital but signals a positive growth outlook for FY2026 following its strategic transformation and capital support.

Cann Group Limited delivered record production and revenue growth in Q4 FY2025, securing new funding and advancing a major debt restructuring to set the stage for profitability in FY2026.

Freehill Mining Ltd reported a challenging quarter ending June 2025 with net cash outflows from operations, but anticipates improved revenues from its Chilean operations as it ramps up activity.

DigitalX Limited reported a 32.8% increase in digital asset holdings to $72.9 million and raised $20.7 million to pivot its treasury strategy firmly towards Bitcoin. The DigitalX Bitcoin ETF (BTXX) also surged, nearing $53 million in assets under management.

Hydralyte USA reported an 8.5% rise in Q2 FY25 net sales, driven by strong May performance and improved margins, while preparing to launch new brain and gut health products.

Felix Group Holdings Ltd reported a strong FY25 with record contract expansions and new customer acquisitions, boosting enterprise ARR by 20% and achieving positive operating cash flow for the first time. The company is now focused on monetising its growing Vendor Marketplace and expanding internationally.

Burgundy Diamond Mines reported a solid Q2 2025 with increased ore production, $52 million in diamond sales, and a significant extension of the Ekati mine life. Strategic shifts and promising project updates set the stage for future growth.

Metgasco reports a 4% dip in quarterly sales revenue and a 9% drop in production, while launching a Production Uplift Program funded by a $750,000 capital raise. Operational improvements at Odin and Vali fields helped slow the decline.

Control Bionics capped a record FY25 with 15% revenue growth, driven by US market gains and expanding NeuroNode and NeuroStrip technologies. The company also achieved a US profitability milestone and is close to finalizing key distribution partnerships.

The Calmer Co. International Limited reported a 6% quarterly revenue increase to $1.9 million in Q4 FY25, driving FY25 revenue to $8.0 million, an 86% year-on-year growth. Key channel expansions and cost efficiencies underpin its progress towards breakeven.